南京聚隆(300644.SZ):未參與金武盾頭盔研發與生產
格隆匯11月7日丨南京聚隆(300644.SZ)在投資者互動平台表示,公司未參與金武盾頭盔研發與生產。我司主要從事高性能高分子新材料、先進複合材料應用的研發、生產製造和銷售,主要產品為高性能改性塑料,熱塑性彈性體材料,碳纖維樹脂基複合材料結構件、零部件及裝配,生物基資源循環塑木型材,產品廣泛應用於汽車及新能源汽車、高鐵及軌道交通、通訊及電子電氣、航空航天及低空經濟、醫療健康、環保建築工程等領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.